Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants.

The Lancet. Microbe

Pallett SJC, Heskin J, Groppelli E, Mazzella A, Moore LSP.
PMID: 34977829
Lancet Microbe. 2021 Dec 23; doi: 10.1016/S2666-5247(21)00337-2. Epub 2021 Dec 23.

No abstract available.

Cite
Pallett SJC, Heskin J, Groppelli E, et al. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants. Lancet Microbe. 2021;doi: 10.1016/S2666-5247(21)00337-2.
Pallett, S. J. C., Heskin, J., Groppelli, E., Mazzella, A., & Moore, L. S. P. (2021). Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants. The Lancet. Microbe, . https://doi.org/10.1016/S2666-5247(21)00337-2
Pallett, Scott J C, et al. "Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants." The Lancet. Microbe vol. (2021). doi: https://doi.org/10.1016/S2666-5247(21)00337-2
Pallett SJC, Heskin J, Groppelli E, Mazzella A, Moore LSP. Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants. Lancet Microbe. 2021 Dec 23; doi: 10.1016/S2666-5247(21)00337-2. Epub 2021 Dec 23. PMID: 34977829; PMCID: PMC8700647.
Copy Download .nbib Format: NLM
Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals.

The Journal of infection

Heskin J, Pallett SJC, Mughal N, Jones R, Rayment M, Davies GW, Moore LSP.
PMID: 34736983
J Infect. 2022 Jan;84(1):e26-e28. doi: 10.1016/j.jinf.2021.10.023. Epub 2021 Nov 01.

No abstract available.

Cite
Heskin J, Pallett SJC, Mughal N, et al. Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals. J Infect. 2021;84(1):e26-e28doi: 10.1016/j.jinf.2021.10.023.
Heskin, J., Pallett, S. J. C., Mughal, N., Jones, R., Rayment, M., Davies, G. W., & Moore, L. S. P. (2022). Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals. The Journal of infection, 84(1), e26-e28. https://doi.org/10.1016/j.jinf.2021.10.023
Heskin, Joseph, et al. "Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals." The Journal of infection vol. 84,1 (2022): e26-e28. doi: https://doi.org/10.1016/j.jinf.2021.10.023
Heskin J, Pallett SJC, Mughal N, Jones R, Rayment M, Davies GW, Moore LSP. Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals. J Infect. 2022 Jan;84(1):e26-e28. doi: 10.1016/j.jinf.2021.10.023. Epub 2021 Nov 01. PMID: 34736983; PMCID: PMC8559300.
Copy Download .nbib Format: NLM
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.

Lancet (London, England)

Heskin J, Pallett SJC, Mughal N, Davies GW, Moore LSP, Rayment M, Jones R.
PMID: 34973713
Lancet. 2022 Jan 01;399(10319):21-22. doi: 10.1016/S0140-6736(21)02657-X.

No abstract available.

Cite
Heskin J, Pallett SJC, Mughal N, et al. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 2022;399(10319):21-22doi: 10.1016/S0140-6736(21)02657-X.
Heskin, J., Pallett, S. J. C., Mughal, N., Davies, G. W., Moore, L. S. P., Rayment, M., & Jones, R. (2022). Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet (London, England), 399(10319), 21-22. https://doi.org/10.1016/S0140-6736(21)02657-X
Heskin, Joseph, et al. "Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management." Lancet (London, England) vol. 399,10319 (2022): 21-22. doi: https://doi.org/10.1016/S0140-6736(21)02657-X
Heskin J, Pallett SJC, Mughal N, Davies GW, Moore LSP, Rayment M, Jones R. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 2022 Jan 01;399(10319):21-22. doi: 10.1016/S0140-6736(21)02657-X. PMID: 34973713.
Copy Download .nbib Format: NLM
A blood-based 22-gene expression signature for hepatocellular carcinoma identification.

Annals of translational medicine

Zheng J, Zhu MY, Wu F, Kang B, Liang J, Heskia F, Shan YF, Zhang XX.
PMID: 32309342
Ann Transl Med. 2020 Mar;8(5):195. doi: 10.21037/atm.2020.01.93.

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies. Early detection of HCC could largely reduce mortalities. Ultrasonography (US) and serum Alpha Fetoprotein (AFP) test are the screening methods that are most frequently applied to...

Cite
Zheng J, Zhu MY, Wu F, et al. A blood-based 22-gene expression signature for hepatocellular carcinoma identification. Ann Transl Med. 2020;8(5):195doi: 10.21037/atm.2020.01.93.
Zheng, J., Zhu, M. Y., Wu, F., Kang, B., Liang, J., Heskia, F., Shan, Y. F., & Zhang, X. X. (2020). A blood-based 22-gene expression signature for hepatocellular carcinoma identification. Annals of translational medicine, 8(5), 195. https://doi.org/10.21037/atm.2020.01.93
Zheng, Jie, et al. "A blood-based 22-gene expression signature for hepatocellular carcinoma identification." Annals of translational medicine vol. 8,5 (2020): 195. doi: https://doi.org/10.21037/atm.2020.01.93
Zheng J, Zhu MY, Wu F, Kang B, Liang J, Heskia F, Shan YF, Zhang XX. A blood-based 22-gene expression signature for hepatocellular carcinoma identification. Ann Transl Med. 2020 Mar;8(5):195. doi: 10.21037/atm.2020.01.93. PMID: 32309342; PMCID: PMC7154425.
Copy Download .nbib Format: NLM
Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer.

Journal of extracellular vesicles

Wei P, Wu F, Kang B, Sun X, Heskia F, Pachot A, Liang J, Li D.
PMID: 32944195
J Extracell Vesicles. 2020 Aug 26;9(1):1809765. doi: 10.1080/20013078.2020.1809765.

Circulating extracellular vesicles (EVs) were recognized as a promising source of diagnostic biomarker. However, there are limited studies published in this area, partly due to the limited number of detection platforms capable of detecting extracellular vesicles. In this study,...

Cite
Wei P, Wu F, Kang B, et al. Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer. J Extracell Vesicles. 2020;9(1):1809765doi: 10.1080/20013078.2020.1809765.
Wei, P., Wu, F., Kang, B., Sun, X., Heskia, F., Pachot, A., Liang, J., & Li, D. (2020). Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer. Journal of extracellular vesicles, 9(1), 1809765. https://doi.org/10.1080/20013078.2020.1809765
Wei, Ping, et al. "Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer." Journal of extracellular vesicles vol. 9,1 (2020): 1809765. doi: https://doi.org/10.1080/20013078.2020.1809765
Wei P, Wu F, Kang B, Sun X, Heskia F, Pachot A, Liang J, Li D. Plasma extracellular vesicles detected by Single Molecule array technology as a liquid biopsy for colorectal cancer. J Extracell Vesicles. 2020 Aug 26;9(1):1809765. doi: 10.1080/20013078.2020.1809765. PMID: 32944195; PMCID: PMC7480466.
Copy Download .nbib Format: NLM
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.

Lancet (London, England)

Heskin J, Pallett SJC, Mughal N, Davies GW, Moore LSP, Rayment M, Jones R.
PMID: 34973713
Lancet. 2022 Jan 01;399(10319):21-22. doi: 10.1016/S0140-6736(21)02657-X.

No abstract available.

Cite
Heskin J, Pallett SJC, Mughal N, et al. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 2022;399(10319):21-22doi: 10.1016/S0140-6736(21)02657-X.
Heskin, J., Pallett, S. J. C., Mughal, N., Davies, G. W., Moore, L. S. P., Rayment, M., & Jones, R. (2022). Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet (London, England), 399(10319), 21-22. https://doi.org/10.1016/S0140-6736(21)02657-X
Heskin, Joseph, et al. "Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management." Lancet (London, England) vol. 399,10319 (2022): 21-22. doi: https://doi.org/10.1016/S0140-6736(21)02657-X
Heskin J, Pallett SJC, Mughal N, Davies GW, Moore LSP, Rayment M, Jones R. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 2022 Jan 01;399(10319):21-22. doi: 10.1016/S0140-6736(21)02657-X. PMID: 34973713.
Copy Download .nbib Format: NLM
Determination of Organophosphorus Pesticide Residues in Greek Virgin Olive Oil by Capillary Gas Chromatography.

Journal of agricultural and food chemistry

Hiskia AE, Atmajidou ME, Tsipi DF.
PMID: 10554279
J Agric Food Chem. 1998 Feb 16;46(2):570-574. doi: 10.1021/jf970427y.

In this study, the occurrence of 15 organophosphorus pesticide residues in Greek virgin olive oil was investigated. Analysis was carried out using capillary gas chromatography with specific detectors (FPD and NPD), after sample extraction with n-hexane and cleanup by...

Cite
Hiskia AE, Atmajidou ME, Tsipi DF. Determination of Organophosphorus Pesticide Residues in Greek Virgin Olive Oil by Capillary Gas Chromatography. J Agric Food Chem. 1998;46(2):570-574doi: 10.1021/jf970427y.
Hiskia, A. E., Atmajidou, M. E., & Tsipi, D. F. (1998). Determination of Organophosphorus Pesticide Residues in Greek Virgin Olive Oil by Capillary Gas Chromatography. Journal of agricultural and food chemistry, 46(2), 570-574. https://doi.org/10.1021/jf970427y
Hiskia, et al. "Determination of Organophosphorus Pesticide Residues in Greek Virgin Olive Oil by Capillary Gas Chromatography." Journal of agricultural and food chemistry vol. 46,2 (1998): 570-574. doi: https://doi.org/10.1021/jf970427y
Hiskia AE, Atmajidou ME, Tsipi DF. Determination of Organophosphorus Pesticide Residues in Greek Virgin Olive Oil by Capillary Gas Chromatography. J Agric Food Chem. 1998 Feb 16;46(2):570-574. doi: 10.1021/jf970427y. PMID: 10554279.
Copy Download .nbib Format: NLM
A benzimidazole-based N-heterocyclic carbene derived from 1,10-phenanthroline.

Organic letters

Metallinos C, Barrett FB, Chaytor JL, Heska ME.
PMID: 15387568
Org Lett. 2004 Sep 30;6(20):3641-4. doi: 10.1021/ol048393k.

[reaction: see text] A catalytically active palladium-complexed tetracyclic N-heterocyclic carbene (NHC) was prepared in three steps from commercially available 1,10-phenanthroline by using a reduction-cyclization-deprotonation sequence. The new carbene framework is a prototype for the development of a series of...

Cite
Metallinos C, Barrett FB, Chaytor JL, et al. A benzimidazole-based N-heterocyclic carbene derived from 1,10-phenanthroline. Org Lett. 2004;6(20):3641-4doi: 10.1021/ol048393k.
Metallinos, C., Barrett, F. B., Chaytor, J. L., & Heska, M. E. (2004). A benzimidazole-based N-heterocyclic carbene derived from 1,10-phenanthroline. Organic letters, 6(20), 3641-4. https://doi.org/10.1021/ol048393k
Metallinos, Costa, et al. "A benzimidazole-based N-heterocyclic carbene derived from 1,10-phenanthroline." Organic letters vol. 6,20 (2004): 3641-4. doi: https://doi.org/10.1021/ol048393k
Metallinos C, Barrett FB, Chaytor JL, Heska ME. A benzimidazole-based N-heterocyclic carbene derived from 1,10-phenanthroline. Org Lett. 2004 Sep 30;6(20):3641-4. doi: 10.1021/ol048393k. PMID: 15387568.
Copy Download .nbib Format: NLM
Building Large Structures with Curved Aromatic Surfaces by Complexing Metals with Phosphangulene.

Journal of the American Chemical Society

Heskia A, Maris T, Aguiar PM, Wuest JD.
PMID: 31657550
J Am Chem Soc. 2019 Nov 27;141(47):18740-18753. doi: 10.1021/jacs.9b08179. Epub 2019 Nov 13.

Phosphangulene (

Cite
Heskia A, Maris T, Aguiar PM, et al. Building Large Structures with Curved Aromatic Surfaces by Complexing Metals with Phosphangulene. J Am Chem Soc. 2019;141(47):18740-18753doi: 10.1021/jacs.9b08179.
Heskia, A., Maris, T., Aguiar, P. M., & Wuest, J. D. (2019). Building Large Structures with Curved Aromatic Surfaces by Complexing Metals with Phosphangulene. Journal of the American Chemical Society, 141(47), 18740-18753. https://doi.org/10.1021/jacs.9b08179
Heskia, Alice, et al. "Building Large Structures with Curved Aromatic Surfaces by Complexing Metals with Phosphangulene." Journal of the American Chemical Society vol. 141,47 (2019): 18740-18753. doi: https://doi.org/10.1021/jacs.9b08179
Heskia A, Maris T, Aguiar PM, Wuest JD. Building Large Structures with Curved Aromatic Surfaces by Complexing Metals with Phosphangulene. J Am Chem Soc. 2019 Nov 27;141(47):18740-18753. doi: 10.1021/jacs.9b08179. Epub 2019 Nov 13. PMID: 31657550.
Copy Download .nbib Format: NLM
Phosphangulene: A Molecule for All Chemists.

Accounts of chemical research

Heskia A, Maris T, Wuest JD.
PMID: 33026221
Acc Chem Res. 2020 Oct 20;53(10):2472-2482. doi: 10.1021/acs.accounts.0c00511. Epub 2020 Oct 07.

Phosphangulene (

Cite
Heskia A, Maris T, Wuest JD. Phosphangulene: A Molecule for All Chemists. Acc Chem Res. 2020;53(10):2472-2482doi: 10.1021/acs.accounts.0c00511.
Heskia, A., Maris, T., & Wuest, J. D. (2020). Phosphangulene: A Molecule for All Chemists. Accounts of chemical research, 53(10), 2472-2482. https://doi.org/10.1021/acs.accounts.0c00511
Heskia, Alice, et al. "Phosphangulene: A Molecule for All Chemists." Accounts of chemical research vol. 53,10 (2020): 2472-2482. doi: https://doi.org/10.1021/acs.accounts.0c00511
Heskia A, Maris T, Wuest JD. Phosphangulene: A Molecule for All Chemists. Acc Chem Res. 2020 Oct 20;53(10):2472-2482. doi: 10.1021/acs.accounts.0c00511. Epub 2020 Oct 07. PMID: 33026221.
Copy Download .nbib Format: NLM
OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis.

Journal of medical virology

Zhu M, Zheng J, Wu F, Kang B, Liang J, Heskia F, Zhang X, Shan Y.
PMID: 32043608
J Med Virol. 2020 Feb 11; doi: 10.1002/jmv.25704. Epub 2020 Feb 11.

Hepatocellular carcinoma (HCC) accounts for 90% of cases of liver cancer and is one of the most common and lethal malignancies among all cancers. Current screening practices in high-risk populations using ultrasound and serological α-fetoprotein (AFP) have significantly reduced...

Cite
Zhu M, Zheng J, Wu F, et al. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis. J Med Virol. 2020;doi: 10.1002/jmv.25704.
Zhu, M., Zheng, J., Wu, F., Kang, B., Liang, J., Heskia, F., Zhang, X., & Shan, Y. (2020). OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis. Journal of medical virology, . https://doi.org/10.1002/jmv.25704
Zhu, Mingyu, et al. "OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis." Journal of medical virology vol. (2020). doi: https://doi.org/10.1002/jmv.25704
Zhu M, Zheng J, Wu F, Kang B, Liang J, Heskia F, Zhang X, Shan Y. OPN is a promising serological biomarker for hepatocellular carcinoma diagnosis. J Med Virol. 2020 Feb 11; doi: 10.1002/jmv.25704. Epub 2020 Feb 11. PMID: 32043608.
Copy Download .nbib Format: NLM
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.

Lancet (London, England)

Heskin J, Pallett SJC, Mughal N, Davies GW, Moore LSP, Rayment M, Jones R.
PMID: 34973713
Lancet. 2022 Jan 01;399(10319):21-22. doi: 10.1016/S0140-6736(21)02657-X.

No abstract available.

Cite
Heskin J, Pallett SJC, Mughal N, et al. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 2022;399(10319):21-22doi: 10.1016/S0140-6736(21)02657-X.
Heskin, J., Pallett, S. J. C., Mughal, N., Davies, G. W., Moore, L. S. P., Rayment, M., & Jones, R. (2022). Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet (London, England), 399(10319), 21-22. https://doi.org/10.1016/S0140-6736(21)02657-X
Heskin, Joseph, et al. "Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management." Lancet (London, England) vol. 399,10319 (2022): 21-22. doi: https://doi.org/10.1016/S0140-6736(21)02657-X
Heskin J, Pallett SJC, Mughal N, Davies GW, Moore LSP, Rayment M, Jones R. Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management. Lancet. 2022 Jan 01;399(10319):21-22. doi: 10.1016/S0140-6736(21)02657-X. PMID: 34973713; PMCID: PMC8718360.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries